Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas

(2011) Pierre Vanden Borre et al.   CELLULAR SIGNALLING

Tumor control versus adverse events with targeted anticancer therapies

(2011) Dorothy M. K. Keefe et al.   Nature Reviews Clinical Oncology

Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer

(2010) M F E Godinho et al.   BRITISH JOURNAL OF CANCER

Estrogen Receptor Mutations and Changes in Downstream Gene Expression and Signaling

(2010) I. Barone et al.   CLINICAL CANCER RESEARCH

Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells

(2010) Marcia Godinho et al.   JOURNAL OF CELLULAR PHYSIOLOGY

The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells

(2009) Arend Brinkman et al.   BREAST CANCER RESEARCH AND TREATMENT

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

(2009) T van Agthoven et al.   BRITISH JOURNAL OF CANCER

CAS proteins in normal and pathological cell growth control

(2009) Nadezhda Tikhmyanova et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern

(2009) Anthony Makkinje et al.   CELLULAR SIGNALLING

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response

(2009) Ton van Agthoven et al.   ENDOCRINE-RELATED CANCER

Functional identification of genes causing estrogen independence of human breast cancer cells

(2008) Ton van Agthoven et al.   BREAST CANCER RESEARCH AND TREATMENT

Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer

(2008) D. Meijer et al.   ENDOCRINE-RELATED CANCER

Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance

(2008) Ton van Agthoven et al.   JOURNAL OF CLINICAL ONCOLOGY

Multiplexed Cell Signaling Analysis of Human Breast Cancer Applications for Personalized Therapy

(2008) Julia D. Wulfkuhle et al.   JOURNAL OF PROTEOME RESEARCH